DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aptech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·13 Oct 2026, 7:28 am

Aptech

Aptech Limited has received a certificate from the depositories, indicating that it has complied with the SEBI (Depositories and Participants) Regulations, 2018. This regulatory compliance is a standard requirement for entities that deal with securities and dematerialized shares.

For investors, this news is largely procedural and does not signal any immediate financial change or operational risk. It confirms that the company is adhering to the necessary legal frameworks for its shareholding structure.

Investors should focus on the company's core business performance and market trends rather than this regulatory filing. This document is a routine administrative update and does not alter the investment outlook for Aptech.